241 related articles for article (PubMed ID: 23575476)
1. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors.
Matse JH; Yoshizawa J; Wang X; Elashoff D; Bolscher JG; Veerman EC; Bloemena E; Wong DT
Clin Cancer Res; 2013 Jun; 19(11):3032-8. PubMed ID: 23575476
[TBL] [Abstract][Full Text] [Related]
2. Human Salivary Micro-RNA in Patients with Parotid Salivary Gland Neoplasms.
Matse JH; Yoshizawa J; Wang X; Elashoff D; Bolscher JG; Veerman EC; Leemans CR; Pegtel DM; Wong DT; Bloemena E
PLoS One; 2015; 10(11):e0142264. PubMed ID: 26544193
[TBL] [Abstract][Full Text] [Related]
3. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
4. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
[TBL] [Abstract][Full Text] [Related]
5. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
7. Capsule of parotid gland tumor: evaluation by 3.0 T magnetic resonance imaging using surface coils.
Ishibashi M; Fujii S; Kawamoto K; Nishihara K; Matsusue E; Kodani K; Kaminou T; Ogawa T
Acta Radiol; 2010 Dec; 51(10):1103-10. PubMed ID: 20883183
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate antigen 19-9 in saliva: possible preoperative marker of malignancy in parotid tumors.
Dyckhoff G; Warta R; Gonnermann A; Plinkert PK; Flechtenmacher C; Volkmann M
Otolaryngol Head Neck Surg; 2011 Nov; 145(5):772-7. PubMed ID: 21746840
[TBL] [Abstract][Full Text] [Related]
9. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
11. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
12. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer.
Xie Z; Yin X; Gong B; Nie W; Wu B; Zhang X; Huang J; Zhang P; Zhou Z; Li Z
Cancer Prev Res (Phila); 2015 Feb; 8(2):165-73. PubMed ID: 25538087
[TBL] [Abstract][Full Text] [Related]
13. Effects of benign parotid tumors on unstimulated saliva secretion from the parotid gland.
Jezewska E; Scinska A; Kukwa W; Bienkowski P
Auris Nasus Larynx; 2009 Oct; 36(5):586-9. PubMed ID: 19249167
[TBL] [Abstract][Full Text] [Related]
14. Pattern of parotid gland tumors on Crete, Greece: a retrospective study of 131 cases.
Drivas EI; Skoulakis CE; Symvoulakis EK; Bizaki AG; Lachanas VA; Bizakis JG
Med Sci Monit; 2007 Mar; 13(3):CR136-40. PubMed ID: 17325637
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
16. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland tumors in an Iranian population: a retrospective study of 130 cases.
Ansari MH
J Oral Maxillofac Surg; 2007 Nov; 65(11):2187-94. PubMed ID: 17954313
[TBL] [Abstract][Full Text] [Related]
19. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
Kim BS; Kim SJ; Pak K
Ann Nucl Med; 2016 Jun; 30(5):346-54. PubMed ID: 26897010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
